Life Science Executive Awards
Monday 16 November 2026City Central at the HAC, London, UKM&A of the Year
This award recognises the teams and organisations who have executed a truly transformational and high value M&A (full purchase or asset acquisition) deal for both the company and the wider industry.
Criteria & Judging
Qualifying criteria:
- The lead company must be a European Life Science company
- Open to private, public companies, pharma, commercial leaders or big tech
- Deal must be an M&A deal NOT a license, partnership or alliance
- Deal to have completed in the period between 1 September 2025 and 1 August 2026
Judges will be paying particular attention to:
- Uniqueness or novelty of deal strategy / terms and structure
- Level of value creation / size of deal
- Strength of partner / partnership and deal teams
- Potential game / industry changing implications within next 12-months
- Post-deal performance
